|
Primary
|
|
Hospitalization, N (%)
|
14 (5.60)
|
21 (8.37)
|
0.65 (0.32–1.31)
|
0.227
|
|
Secondary
|
|
Time to hospitalization days (in those who were hospitalized), median (IQR)
|
3.5 (3–5)
|
3 (2–5)
|
–
|
0.59
|
|
Invasive MVS, N (%)
|
4 (1.60)
|
3 (1.20)
|
1.34 (0.30–6.07)
|
0.70
|
|
Time to invasive MVS days (in those who required MVS), mean (±SD)
|
5.25 (1.71)
|
10 (2)
|
–
|
0.019
|
|
Negative nasal swab day 3, N (%)
|
113 (47.08)
|
120 (49.79)
|
0.90 (0.63–1.28)
|
0.55
|
|
Negative nasal swab day 12, N (%)
|
212 (89.08)
|
221 (92.47)
|
0.76 (0.45–1.27)
|
0.29
|
|
Dialysis, N (%)
|
1 (0.40)
|
1 (0.40)
|
1.00 (0.06–16.14)
|
1
|
|
All-cause mortality, N (%)
|
4 (1.60)
|
3 (1.20)
|
1.34 (0.30–6.07)
|
0.70
|
|
Safety (adverse events)#, total (%) *
|
45 (18.00)
|
53 (21.11)
|
–
|
0.6
|
